NDC 17856-1124-01 - Metamucil Therapy for regularity
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1124
- Requested NDC
- 17856-1124-01
- Package NDCs from labels
- 17856-1124-1, 17856-1124-2, 17856-1124-01
- Manufacturer
- Atlantic Biologicals Corp.
- Effective date
- 2026-08-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metamucil Therapy for regularity - Atlantic Biologicals Corp. | Atlantic Biologicals Corp. | 2026-08-05 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener Laxative | DOCUSATE SODIUM | QUALITY CHOICE (Chain Drug Marketing Association) | 96c7f8bc-be95-40d1-9977-44b7cc6582df | 2024-04-22 | Warnings | M007 |
| Pedia-Lax | MAGNESIUM HYDROXIDE | C.B. Fleet Company, Inc. | 975f24d8-218c-40f4-84a5-558acf34329d | 2024-04-11 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | H E B | 2f9e2723-53a7-47a8-8c41-87bffc4e50dd | 2024-04-09 | Warnings | M007 |
| Senna | SENNOSIDES | H E B | d047e4e9-b8ac-498e-9fde-8af5d415edaa | 2024-04-09 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | H E B | 5b8bcc6c-de03-4d73-a76f-6f4c371cf250 | 2024-04-09 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | H E B | 1dd2be7e-bdca-4e43-b853-3ed10b636632 | 2024-04-08 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | Bryant Ranch Prepack | 1f11cf85-b094-4ca4-8b48-2d3a9093304b | 2024-04-04 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | TARGET Corporation | 89106733-69f1-469b-9d07-f06ac09b2fb6 | 2024-04-02 | Warnings | M007 |
| Stool Softener Laxative Plus Stimulant | DOCUSATE SODIUM AND SENNOSIDES | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 89dc2063-6744-4412-89be-90990090b57c | 2024-03-19 | Warnings | M007 |
| Senna Laxative | SENNOSIDES | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 2322765d-6f08-48d4-a500-818a8a558f6f | 2024-03-19 | Warnings | M007 |
| Stool Softener Laxative Plus Stimulant | DOCUSATE SODIUM AND SENNOSIDES | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | dcab26ff-2c10-4478-90a8-c89d87261bfa | 2024-03-19 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 4d1391da-7874-4a51-a468-2843ecf6f92b | 2024-03-18 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | adaea845-e029-422d-a947-d8ce8f5787ed | 2024-03-18 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 8b033d56-b95b-4905-9f33-cf2fbd61ce35 | 2024-03-15 | Warnings | M007 |
| Stool Softener Plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | CVS Pharmacy | 6a97a181-1ec2-473d-a588-db2f2f2f662d | 2024-03-14 | Warnings | M007 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | CVS Pharmacy | dcd27653-4c81-4630-a8b7-5fb5dc3e976a | 2024-03-13 | Warnings | M007 |
| EX-LAX REGULAR STRENGTH STIMULANT LAXATIVE | SENNOSIDES | Haleon US Holdings LLC | 62544c2f-6e30-4cec-ae63-233715ef0699 | 2024-03-13 | Warnings | M007 |
| Laxative Stool Softener | DOCUSATE SODIUM, SENNOSIDES | CVS Pharmacy | b52181e3-fd84-479e-8590-18619f6c0dae | 2024-03-13 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | CVS Pharmacy | 5eb047d2-8317-4de3-9268-d206ca039e3d | 2024-03-13 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | CVS Pharmacy | f77c65b0-3e13-48ce-a2d9-36a9eba1851f | 2024-03-07 | Warnings | M007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.